Healthcare & Life Sciences
VBL Therapeutics
Israelwww.vblrx.com
VBL Therapeutics is a Healthcare & Life Sciences startup based in Israel, most recent round Series B, 4 tracked investors.
Activeseries-b
series-b
Stage
4
Investors
About VBL Therapeutics
Based in Israel, VBL Therapeutics is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
VBL Therapeutics is a clinical-stage biopharmaceutical company developing targeted antibody therapies for immune-inflammatory diseases using proprietary monocyte targeting technology, with a lead candidate VB-601 entering Phase 1 in early 2023.
Explore VBL Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.